from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2282c/-

LFCtreatmentdescriptionclass of inhibitor

0.420

Amikacinug/mL Amikacintranslation

-0.000

Cap5-10ug/mL Capreomycintranslation

0.544

Rox10-50 ug/mL Roxithromycintranslation

0.025

SM2-5 ug/mL Streptomycintranslation

-0.859

Tet5-10 ug/mL Tetracyclinetranslation

1.027

Rif0.2-5ug/mL Rifampicintranscription

0.569

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.334

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.953

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.654

CPZ10-50 ug/mL Chlorpromazinerespiration

-2.751

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.201

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.448

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.525

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.733

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.122

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.646

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.557

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.051

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.374

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.631

Nigericin50 uM Nigericinrespiration

-0.422

TRC10-150 ug/mL Triclosanrespiration

-1.274

TRZ10-25 ug/mL Thioridazinerespiration

0.913

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.956

menadione6-10 ug/mL Menadionerespiration

-0.360

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.026

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.335

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.233

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.914

NRP_1Non-replicating persistence stage 1dosRassociated

0.278

Amp0.2mg/mL AmpicillincellWall

0.214

Cephalexin20-100 ug/mL CephalexincellWall

0.101

Cerulenin0.32-5 ug/mL CerulenincellWall

0.419

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.214

EMB10-20 ug/mL EthambutolcellWall

0.233

Eta12-40 ug/mL EthionamidecellWall

-0.175

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.024

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.425

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.607

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.140

BZA0.12 mg/mL BenzamidearomaticAmides

-0.092

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.244

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.710

H2O24 mM hydrogen peroxideDNAdamaging

0.217

Levo10 ug/mL LevofloxacinDNAdamaging

0.375

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.594

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.138

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.031

UVUV-irradiationDNAdamaging

-0.721

ARP41-4 ug/mL Antitubercular compound ARP4?

0.031

Antimycin12.5-50 ug/mL Antimycin A?

0.088

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.043

PA_110-50 ug/mL Antitubercular compound PA-1?

0.064

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.985

PA8240.2-2 ug/mL PA-824?

-1.027

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.117

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.096

Verapamil50 uM Verapamil?

0.900

mercaptoethanol2 mM 2-Mercaptoethanol?

0.045

methoxatin10-20 ug/mL Methoxatin?